Company / Capital Returned to Shareholders per Share
IRONWOOD PHARMACEUTICALS INC Capital Returned to Shareholders per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.81
FY2024
5-year range
$0.15 / $0.81
FY2021-FY2024
Trend
-
vs FY2023
Sector context
#23 of 51
Health Care
What the data says
Capital Returned to Shareholders per Share changed +443% YoY in FY2024, a notable deviation from the 2-year average annual change of +221%.
Based on SEC 10-K filings.
0.81 in FY2024.
Improved from $0.15 to $0.81 over the past 3 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +75.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#23 of 51 in Health CareTop 45% of 51This company $0.81 Sector average $2.74
▼
-70.4% below sector average
Key checks
Key Insights
- Ranks #23 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.81 | - |
| FY2023 | - | - |
| FY2022 | $0.15 | -0.9% |
| FY2021 | $0.15 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026